As a mage, I just want to pursue the truth
Chapter 24 Epic Discoveries: Approaches to Alleviating Addiction
Chapter 24 Epic Discoveries: Approaches to Alleviating Addiction
The investors in the audience gathered together in twos and threes to chat, some of them exchanged words like Young and Wang Hongbo, and some chatted like friends about things that had nothing to do with work.
Lei Jun was wearing the blue shirt he has worn countless times in public and walked up to the stage to speak:
"Welcome everyone to the sharing meeting of Kechuang Bio. As one of the shareholders of Kechuang Biology, I will first help Zheng Li warm up the scene."
"It's a sharing session. We do have something to share with you, but there is another layer that we want to introduce a second round of investment."
"Originally, when I was chatting with Zheng Li in private, I said that I would invest all of the second round of investment for you. Just tell me how much you want, and I will cover it all."
"Then Zheng Li showed me a document, which is the document I want to share with you today. After reading it, I fell silent because it was too expensive and I couldn't afford it."
After Lei Jun said this, the investors in the audience looked at each other. Lei Jun couldn't afford it. How high is the valuation of the second round of investment?
"And from another perspective, a company has more investors, which is conducive to the growth of the company."
"After all, the industry I have been engaged in is mainly the Internet industry, so the only thing I can provide in the biomedical industry is funds."
"A successful company can't grow only by funds, we need more investors to support its growth."
"We have sent invitation letters to everyone. Since you are willing to participate in the sharing meeting of Kechuangbiology, I assume that you have the intention to invest."
"Many people in the audience are acquaintances, such as IDG, Qiming Venture Partners and Morningside Capital. These investment institutions participated in Rice's A-round investment. At that time, I went everywhere to meet investors, and the A-round investment only received 4100 million. Dollar."
"When Zheng Li found me, he said that it was my fans who wanted to chat with me. I thought it would be a little smug to have fans who published nature papers at the age of 18, plus our relationship with seniors and juniors."
"I just chatted with him, and it turned out that something went wrong. The half-hour phone call took away 5000 million from me, but the unit is RMB."
"I even wanted to give him more money."
"Like Liu Qin of Morningside Capital and I are old acquaintances. Morningside Capital only invested in Internet companies before. Not long ago, Liu Qin asked me when your second round of investment in science and technology biotechnology will start?"
"Can we vote for it too?"
"In addition, there are too many investors who have found me because of this incident recently. Do they all say that they are short of money? The clinical trials in the second and third phases of the clinical trial must be short of money. The clinical trials in Europe and the United States are more expensive, and we need to invest some money. Is there any money for you?"
"This is really a trouble of happiness. Investors are rushing to send money. It reminds me of the days when Da Mila invested. I still feel a little sad. Seniors are not as good as juniors."
"Come back to business, after today's sharing session is over, everyone's willingness to invest in science and technology will definitely become stronger."
"Let us welcome Zheng Lilai, the chairman of Kechuang Biotech, to share with you the latest developments of the company."
At 35:5 p.m., Zheng Li waited for [-] minutes before walking onto the stage:
"Mr. Lei's speech is so good, everyone in the audience listened with great interest, and my speech may be much boring."
After staying in Blue Star for almost a year, Zheng Lixin has a good command of idioms.
"I think everyone has a general understanding of endorphins. Today I will mainly introduce some things that you don't understand."
"First of all, the synthesis cost of endorphin industrial synthesis pathway is at most 20.00% higher than that of morphine, but its analgesic effect is ten times that of morphine."
"But endorphins are much more addictive than morphine or any other opioid pain medication."
If we only look at the analgesic effect, the analgesic effect of fentanyl is 50-100 times that of morphine.And the synthetic cost of fentanyl is almost the same as that of morphine.
But this thing is too addictive, no less than heroin.
"Simply speaking, moderate use of endorphins will not cause addiction, which is good news for all cancer patients."
"In addition, I recently made a major discovery that injections of endorphins and lipoprotein trypsin peptides in a certain dose ratio can effectively reduce patients' dependence on opioids after a course of treatment."
"Including opioid pins like heroin."
As soon as the words fell, the investors in the audience were boiling. This is an epic discovery. If it is true, Zheng Li is more than enough to win the Nobel Prize for this.
To know about the topic of reducing addiction, countless scientists from academia to industry have made attempts over the years.
Regardless of whether it is at the level of drugs or cognitive behavior, scientists have used countless methods without obtaining a good solution.
More importantly, this means that there is hope for the cure or reduction of drug addiction. This market is extremely broad, and it is equivalent to a monopoly market.
Almost everyone in the Zheng Li stands raised their hands, with doubts written all over their faces, and he signaled: "The staff pass the microphone to the lady at the front of the stage."
The lady at the front was none other than Goldman Sachs' Stephanie, and she got to the point:
"Hello, Director Zheng, I'm sorry that my question may offend you a bit, so I apologize first."
"But I believe these questions are also the questions of all our investors present."
"To what extent is endorphin combined with another drug administered in a regimen effective in reducing opioid addiction in patients?"
Zheng Li replied: "We have achieved a radical cure in mice. As long as it is no longer exposed to opioids, it will not become dependent on opioids."
Stephanie couldn't believe it: "Is what you said true?"
Zheng Li said solemnly: "It's absolutely true!"
Stephanie: "Sorry this news is so shocking, I thank you for the countless addicts."
"But I still want to ask, Kechuang Bio is about to conduct a second round of venture capital investment. Now that you have revealed to us this unprecedented benefit, I have some doubts about its authenticity."
"None of us want the incident of Holmes to happen again. Holmes' company claims to be able to test for cancer by dropping blood, and finally found that the effect she claimed could not be realized at all."
Stephanie was afraid that Zheng Liyoung would not know who Elizabeth Holmes was.
"I don't doubt you, I just want to confirm the authenticity of your news."
Zheng Li nodded and said: "I can understand your concerns. Regarding this discovery, I have written the experimental process and conclusion into a paper and sent it to The Lancet."
"The editor of "The Lancet" successfully reproduced the experiment and the experimental results in mice after receiving the endorphin and lipotropin trypsin peptide from me."
"The paper will be on the cover of the latest issue of The Lancet. You can also contact your trusted laboratory to reproduce the experimental steps in it."
(End of this chapter)
The investors in the audience gathered together in twos and threes to chat, some of them exchanged words like Young and Wang Hongbo, and some chatted like friends about things that had nothing to do with work.
Lei Jun was wearing the blue shirt he has worn countless times in public and walked up to the stage to speak:
"Welcome everyone to the sharing meeting of Kechuang Bio. As one of the shareholders of Kechuang Biology, I will first help Zheng Li warm up the scene."
"It's a sharing session. We do have something to share with you, but there is another layer that we want to introduce a second round of investment."
"Originally, when I was chatting with Zheng Li in private, I said that I would invest all of the second round of investment for you. Just tell me how much you want, and I will cover it all."
"Then Zheng Li showed me a document, which is the document I want to share with you today. After reading it, I fell silent because it was too expensive and I couldn't afford it."
After Lei Jun said this, the investors in the audience looked at each other. Lei Jun couldn't afford it. How high is the valuation of the second round of investment?
"And from another perspective, a company has more investors, which is conducive to the growth of the company."
"After all, the industry I have been engaged in is mainly the Internet industry, so the only thing I can provide in the biomedical industry is funds."
"A successful company can't grow only by funds, we need more investors to support its growth."
"We have sent invitation letters to everyone. Since you are willing to participate in the sharing meeting of Kechuangbiology, I assume that you have the intention to invest."
"Many people in the audience are acquaintances, such as IDG, Qiming Venture Partners and Morningside Capital. These investment institutions participated in Rice's A-round investment. At that time, I went everywhere to meet investors, and the A-round investment only received 4100 million. Dollar."
"When Zheng Li found me, he said that it was my fans who wanted to chat with me. I thought it would be a little smug to have fans who published nature papers at the age of 18, plus our relationship with seniors and juniors."
"I just chatted with him, and it turned out that something went wrong. The half-hour phone call took away 5000 million from me, but the unit is RMB."
"I even wanted to give him more money."
"Like Liu Qin of Morningside Capital and I are old acquaintances. Morningside Capital only invested in Internet companies before. Not long ago, Liu Qin asked me when your second round of investment in science and technology biotechnology will start?"
"Can we vote for it too?"
"In addition, there are too many investors who have found me because of this incident recently. Do they all say that they are short of money? The clinical trials in the second and third phases of the clinical trial must be short of money. The clinical trials in Europe and the United States are more expensive, and we need to invest some money. Is there any money for you?"
"This is really a trouble of happiness. Investors are rushing to send money. It reminds me of the days when Da Mila invested. I still feel a little sad. Seniors are not as good as juniors."
"Come back to business, after today's sharing session is over, everyone's willingness to invest in science and technology will definitely become stronger."
"Let us welcome Zheng Lilai, the chairman of Kechuang Biotech, to share with you the latest developments of the company."
At 35:5 p.m., Zheng Li waited for [-] minutes before walking onto the stage:
"Mr. Lei's speech is so good, everyone in the audience listened with great interest, and my speech may be much boring."
After staying in Blue Star for almost a year, Zheng Lixin has a good command of idioms.
"I think everyone has a general understanding of endorphins. Today I will mainly introduce some things that you don't understand."
"First of all, the synthesis cost of endorphin industrial synthesis pathway is at most 20.00% higher than that of morphine, but its analgesic effect is ten times that of morphine."
"But endorphins are much more addictive than morphine or any other opioid pain medication."
If we only look at the analgesic effect, the analgesic effect of fentanyl is 50-100 times that of morphine.And the synthetic cost of fentanyl is almost the same as that of morphine.
But this thing is too addictive, no less than heroin.
"Simply speaking, moderate use of endorphins will not cause addiction, which is good news for all cancer patients."
"In addition, I recently made a major discovery that injections of endorphins and lipoprotein trypsin peptides in a certain dose ratio can effectively reduce patients' dependence on opioids after a course of treatment."
"Including opioid pins like heroin."
As soon as the words fell, the investors in the audience were boiling. This is an epic discovery. If it is true, Zheng Li is more than enough to win the Nobel Prize for this.
To know about the topic of reducing addiction, countless scientists from academia to industry have made attempts over the years.
Regardless of whether it is at the level of drugs or cognitive behavior, scientists have used countless methods without obtaining a good solution.
More importantly, this means that there is hope for the cure or reduction of drug addiction. This market is extremely broad, and it is equivalent to a monopoly market.
Almost everyone in the Zheng Li stands raised their hands, with doubts written all over their faces, and he signaled: "The staff pass the microphone to the lady at the front of the stage."
The lady at the front was none other than Goldman Sachs' Stephanie, and she got to the point:
"Hello, Director Zheng, I'm sorry that my question may offend you a bit, so I apologize first."
"But I believe these questions are also the questions of all our investors present."
"To what extent is endorphin combined with another drug administered in a regimen effective in reducing opioid addiction in patients?"
Zheng Li replied: "We have achieved a radical cure in mice. As long as it is no longer exposed to opioids, it will not become dependent on opioids."
Stephanie couldn't believe it: "Is what you said true?"
Zheng Li said solemnly: "It's absolutely true!"
Stephanie: "Sorry this news is so shocking, I thank you for the countless addicts."
"But I still want to ask, Kechuang Bio is about to conduct a second round of venture capital investment. Now that you have revealed to us this unprecedented benefit, I have some doubts about its authenticity."
"None of us want the incident of Holmes to happen again. Holmes' company claims to be able to test for cancer by dropping blood, and finally found that the effect she claimed could not be realized at all."
Stephanie was afraid that Zheng Liyoung would not know who Elizabeth Holmes was.
"I don't doubt you, I just want to confirm the authenticity of your news."
Zheng Li nodded and said: "I can understand your concerns. Regarding this discovery, I have written the experimental process and conclusion into a paper and sent it to The Lancet."
"The editor of "The Lancet" successfully reproduced the experiment and the experimental results in mice after receiving the endorphin and lipotropin trypsin peptide from me."
"The paper will be on the cover of the latest issue of The Lancet. You can also contact your trusted laboratory to reproduce the experimental steps in it."
(End of this chapter)
You'll Also Like
-
I raised demonic beasts in Douluo Continent, which shocked Gu Yuena.
Chapter 114 2 hours ago -
While writing a diary in Douluo Continent, Qian Renxue was thoroughly teased.
Chapter 137 2 hours ago -
In this crossover anime, I've been bound to two systems.
Chapter 125 2 hours ago -
The hero's gender is yet to be determined after rebirth.
Chapter 328 2 hours ago -
Comparison of the two Hokage: Both ninja worlds are devastated.
Chapter 185 2 hours ago -
Douluo Continent: I teach and nurture students at Tianshui Academy!
Chapter 113 2 hours ago -
One Piece meme: Starting with eight extraordinary skills
Chapter 333 2 days ago -
Pokémon: I picked up a reborn Eevee at the start of the game.
Chapter 515 2 days ago -
Type-Moon: My Destiny Guide
Chapter 376 2 days ago -
Divine Seal: From a Heavy Sword to Slicing Through the Holy Demon Continent
Chapter 247 2 days ago